QIAGEN Clinical Insight bioinformatics platform expanded

Friday, 06 November, 2015 | Supplied by: QIAGEN Pty Ltd


The QIAGEN Clinical Insight (QCI) clinical decision support solution streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories. The bioinformatics platform has been expanded from interpreting NGS data on somatic mutations in solid tumour cancers to add leukaemia and lymphoma testing, as well as testing for hereditary cancer indications.

The product enables labs to efficiently provide the valuable molecular insights made possible by next-generation sequencing. For somatic cancer indications, the enhancements include insights for diagnostic testing as well as monitoring and progression, support for copy number variations (CNVs) and fusion genes, and additional prognostics data from the literature.

The unit now provides comprehensive cover of FDA- and EMA-approved drug labels, NCCN, ASCO and ESMO professional guidelines, and active genotype-related clinical trials to complement comprehensive coverage of literature references and a wide range of reported case databases. The enhancements also add 32 hereditary cancer genes to QCI's coverage, providing a more complete solution for laboratories to interpret and report on germline variants, including support for NGS comprehensive cancer panels testing for both somatic and inherited cancers.

The product now includes comprehensive curation of the hereditary cancer literature and curated clinical case counts for common heritable cancers including breast and ovarian cancer, Lynch syndrome, Peutz-Jegher syndrome, ataxia telangiectasia, neurofibromatosis, hereditary diffuse gastric cancer, familial prostate cancer, polyposis and more.

Online: www.qiagen.com
Phone: 03 9840 9800
Related Products

Lonza 4D-Nucleofector LV Unit PRO electroporation unit

Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...

Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)

The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...

Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms

The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd